MBI's media team has the skills and relationships with national and international print, online and broadcast media to get your story told.
MBI has a seasoned investor relations team and a proven track record of building or restoring credibility with investors and analysts.
MBI brings a fresh, strategic approach to business development for its clients within the biotechnology, medical device, and life sciences industries.
MBI specializes in branding and rebranding private and public life science companies. A clear and consistent corporate identity is the keystone to a successful communications plan.
Image Building | Visual Branding
MBI understands that corporate credibility is one of the most important assets a company can build and that it is one of the hardest to repair when damaged by a crisis.
There are over 1,000 life science industry conferences scheduled around the
world each year... Learn
03/04/14 - Enanta Pharmaceuticals Announces New Data Presented on
Protease Inhibitor ABT-493 at the 21st Conference on Retroviruses and
Opportunistic Infections (CROI)
03/03/14 - Enanta Pharmaceuticals: PEARL-III Study Results in
Patients with Chronic Hepatitis C Presented at the 21st Conference on
Retroviruses and Opportunistic Infections (CROI)
02/14/14 - Enzymatics Launches Archer™ Targeted Sequencing
Technology to Dramatically Enhance Gene Mutation Identification and
Biomedical Clients in
Come and schedule meetings with our clients during the week of
January 13-16, 2014
© 2013 MacDougall Biomedical